Health Condition 1: L649- Androgenic alopecia, unspecified
Conditions
Interventions
Intervention1: PRP: Platelet rich plasma (PRP) was injected in 1st group (PRP group) monthly for 3 months after hair transplant by FUE technique.
Control Intervention1: CGF: Concentrated growth factor
Sponsors
Institute of Dental Studies and Technologies Modinagar
Eligibility
Inclusion criteria
Inclusion criteria: Male patients in the age group of 20-55 years willing to give informed consent. Patients with androgenic alopecia stage III-VII Hamilton-Norwood classification. Patient should not have taken any form of treatment for androgenic alopecia at least in the 3 months.
Exclusion criteria
Exclusion criteria: Patients with alopecia other than androgenic alopecia such as alopecia areata, alopecia totalis, telogen effluvium and acquired cicatricial alopecia. Patients with history of bleeding disorders, autoimmune disorders, psoriasis or lichen planus. Patients on anticoagulant medications- aspirin, warfarin, heparin. Patients with infection locally. Patients who are HIV, hepatitis B or hepatitis C positive or otherwise immunocompromised.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation in terms of change in hair density (percentage of number of grafts at a given time), recovery from redness, length of shaft, texture and thickness of hairTimepoint: 2 weeks, 4 weeks, 8 weeks, 3 months, 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Graft survivabilityTimepoint: 2 weeks, 4 weeks, 8 weeks, 3 months, 6 months | — |
Countries
India
Contacts
Public ContactDr Gaurav Mittal
Institute of Dental Studies and Technologies, Modinagar
Outcome results
None listed